SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?


To: Jibacoa who wrote (2136)1/15/2008 12:31:59 PM
From: Jibacoa  Respond to of 3722
 
Somewhat O.T.<g>

The FDA has ruled that food from certain cloned animals and their offspring is as safe as other food, opening the door for using the controversial technology in the U.S. food supply.

It confirmed preliminary findings in a final risk assessment on cloning on Tuesday.

According to them: "Extensive evaluation of the available data has not identified any subtle hazards that might indicate food consumption risks in healthy clones of cattle, swine or goats."

But the FDA said it didn't have enough information to make the same assertion about cloned sheep.<g>

I haven't looked into which companies may benefit from this FDA's ruling.<g>

Bernard



To: Jibacoa who wrote (2136)1/22/2008 11:44:06 AM
From: Jibacoa  Read Replies (2) | Respond to of 3722
 
PSTI opened with a DG, was down 18.21% at its intraday L, but is down only 9.67% at present,with volume still < its ADV.<g>

stockcharts.com

Dutton Associates updated its ranking to "buy", with a target of $6.50 <g>

PSTI's cell therapy technology, tries to offer an alternative to bone marrow transplants with cells obtained from the umbilical cord blood & placenta.

The stock made an all time L today.<g>

Bernard